TD-9855 Mass Balance Study

Completed · Phase 1

Conditions studied: ADHD, Fibromyalgia

In brief

The purpose of the study is to evaluate the absorption, distribution, metabolism, and excretion (ADME) of a single oral dose of \[14C\]TD-9855

Key facts

Study ID
NCT01924143
Run by
Theravance Biopharma
People needed
6
Starts
2013-10-01
Expected to finish
2013-12-01
Last updated by the study team
2021-01-19

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.